These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Erdheim-Chester's disease of the heart: a diagnostic conundrum and collision with the same mass in the orbit. Bogáts G; Piros G; Tiszlavicz L; Iványi B; Sasi V; Csepregil L; Simon J; Babik B; Csillik A; Kardos L; Palkó A; Matin K; Hanzély Z; Korányi K; Nyáry I; Végh M; Kolozsvári L; Kahán Z; Bajcsay A; Tóth A; Balázs G; Simor T; Pávics L; Palotás A Heart Surg Forum; 2006; 9(1):E549-54. PubMed ID: 16403713 [TBL] [Abstract][Full Text] [Related]
63. Erdheim-Chester disease involving the brain and the heart. Kawashiri MA; Ishibashi-Ueda H; Funada A; Yoshimuta T; Konno T; Hayashi K; Yamagishi M J Am Coll Cardiol; 2014 Mar; 63(11):1121. PubMed ID: 24486262 [No Abstract] [Full Text] [Related]
64. Neurosurgical biopsy as the initial diagnosis of xanthogranuloma of the Erdheim-Chester disease variety of the infundibulum and optic apparatus: letter to the editor. Abla AA; Wilson DA; Eschbacher JM; Spetzler RF Acta Neurochir (Wien); 2010 May; 152(5):925-7. PubMed ID: 20049489 [No Abstract] [Full Text] [Related]
65. Erdheim-Chester disease with predominant mesenteric localization: lack of efficacy of interferon alpha. Perlat A; Decaux O; Sébillot M; Grosbois B; Desfourneaux V; Meadeb J Joint Bone Spine; 2009 May; 76(3):315-7. PubMed ID: 19119043 [No Abstract] [Full Text] [Related]
66. Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease. Cao XX; Niu N; Sun J; Zhou DB; Li J Ann Hematol; 2018 Jan; 97(1):185-187. PubMed ID: 28831599 [No Abstract] [Full Text] [Related]
67. Response of histiocytoses to imatinib mesylate: fire to ashes. Janku F; Amin HM; Yang D; Garrido-Laguna I; Trent JC; Kurzrock R J Clin Oncol; 2010 Nov; 28(31):e633-6. PubMed ID: 20733125 [No Abstract] [Full Text] [Related]
68. [Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease]. Girszyn N; Arnaud L; Villain D; Kahn JE; Piette AM; Bletry O Rev Med Interne; 2007 Nov; 28(11):770-4. PubMed ID: 17629593 [TBL] [Abstract][Full Text] [Related]
69. [Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature]. Valentini D; Cappelli C; Mizzoni F; Noto C; Toscano D; Foco M; Trasimeni G Clin Ter; 2004 May; 155(5):205-8. PubMed ID: 15344569 [TBL] [Abstract][Full Text] [Related]
70. 3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target. Villa A; Belloni D; Vergani B; Cenci S; Cavalli G; Biavasco R; Rodolfo M; Cangi MG; Doglioni C; Dagna L; Ferrero E; Ferrarini M Ann Rheum Dis; 2019 Jun; 78(6):862-864. PubMed ID: 30487147 [No Abstract] [Full Text] [Related]
72. Successful treatment of central nervous system involved Erdheim-Chester disease by intermediate-dose cytarabine as first-line therapy. Wang JN; Qiu Y; Niu N; Zhang Y; Li J; Zhou DB; Cao XX Acta Oncol; 2020 Mar; 59(3):302-305. PubMed ID: 31559889 [No Abstract] [Full Text] [Related]
73. Unusual Case of Recurrent Pericardial Effusion - Erdheim-Chester Disease. Jang JH; Oh J; Shim HS; Kang SM Circ J; 2019 Jul; 83(8):1762. PubMed ID: 30726803 [No Abstract] [Full Text] [Related]